InsidersTradesSigma
Genocea Biosciences, INC.: insider trades · United States · SEC (Form 4)
SEC:genocea-biosciences-inc-7c7c99US·SEC (Form 4)Mcap 0M€Healthcare
Discover the full management transaction log of Genocea Biosciences, INC., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Operating in the Healthcare sector, Genocea Biosciences, INC. has logged 30 reports. Market capitalisation: €587. The latest transaction was filed on 3 June 2022 — Cession. Among the most active insiders: Duvall Diantha. All data is free.
30
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€3m
23 ops.
Sell Volume
Financial data
FY ended December 2021 · cache
Analyst consensus
Income statement
Revenue1.6 M€
Net income−33.2 M€-2022.9% margin
Valuation
P/Book0.0x
Beta38.32
Balance sheet & cash
Market cap587 €
Total debt17.2 M€
Free Cash Flow−48.7 M€
Debt / Equity125%
Profitability & ownership
ROE-525.8%
ROA-57.6%
% insiders0.0%
% institutions0.0%
Last declaration on 3 June 2022
Declarations30 total
Executives▼Sale◆Signal · 53SEC
€761,355 shares@ €0.055812.88% mcap2.6% of flow
Common Stock
SEC:0001457612-22-000075:0·
Executives▼Sale◆Signal · 56SEC
€2254,023 shares@ €0.055838.25% mcap2.0% of flow
Common Stock
SEC:0001457612-22-000073:0·
Executives▼Sale◆Signal · 45SEC
€881,578 shares@ €0.055815.00% mcap3.1% of flow
Common Stock
SEC:0001457612-22-000074:0·
Executives▼Sale◆Signal · 53SEC
€1412,500 shares@ €0.056424.02% mcap100.0% of flow
Common Stock
SEC:0001457612-22-000070:0·
Executives▼Sale◆Signal · 46SEC
€6,739117,244 shares@ €0.057558.9% of flow
Common Stock
SEC:0001457612-22-000069:0·
Executives▼Sale37SEC
€1,24320,425 shares@ €0.0608100.0% of flow
Common Stock
SEC:0001457612-22-000066:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032317:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032329:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032330:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032322:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032327:0·
Executives▼Sale43SEC
€1,74024,407 shares@ €0.071359.7% of flow
Common Stock
SEC:0001457612-22-000060:0·
Executives▼Sale34SEC
€1,36216,525 shares@ €0.082448.1% of flow
Common Stock
SEC:0001457612-22-000061:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032323:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032331:0·
Executives▼Sale◆Signal · 53SEC
€2082,500 shares@ €0.083335.47% mcap100.0% of flow
Common Stock
SEC:0001457612-22-000062:0·
Executives▼Sale28SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032326:0·
Executives▼Sale37SEC
€361,3305,931,843 shares@ €0.0609100.0% of flow
Common Stock
SEC:0001209191-22-032320:0·
Executives▼Sale44SEC
€4,4693,924 shares@ €1.138939.1% of flow
Common Stock
SEC:0001457612-22-000043:0·
Executives▼Sale34SEC
€1,3801,212 shares@ €1.138948.8% of flow
Common Stock
SEC:0001457612-22-000046:0·
Executives▼Sale37SEC
€1,2421,091 shares@ €1.1389100.0% of flow
Common Stock
SEC:0001457612-22-000044:0·
Executives▼Sale37SEC
€1,097963 shares@ €1.1389100.0% of flow
Common Stock
SEC:0001457612-22-000042:0·
Executives▼Sale41SEC
€1,097963 shares@ €1.138937.7% of flow
Common Stock
SEC:0001457612-22-000045:0·
Executives◆Grant19SEC
037,500 shares0
Common Stock
SEC:0001457612-22-000030:0·
Executives◆Grant11SEC
031,250 shares0
Common Stock
SEC:0001457612-22-000028:0·
25 of 30 declarations
About Genocea Biosciences, INC.
GENOCEA BIOSCIENCES, INC. is a biotechnology company focused on developing immunotherapies for infectious diseases and cancer. The company utilizes its vaccine discovery platform to identify unique immune targets.